A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
Titel:
A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
Auteur:
Kim, Yu Jung Kim, Soyeon Kim, Tae Min Suh, Koung Jin Kim, Miso Kim, Se Hyun Keam, Bhumsuk Kim, Dong-Wan Lee, Jong Seok Heo, Dae Seog